http://rdf.disgenet.org/resource/nanopub/NP629956.RAGvchlGSNK3J6h03MCzyDdV86iHVeSQxMl2h5YJylbpI#head
http://rdf.disgenet.org/resource/nanopub/NP629956.RAGvchlGSNK3J6h03MCzyDdV86iHVeSQxMl2h5YJylbpI
http://www.nanopub.org/nschema#hasAssertion
http://rdf.disgenet.org/resource/nanopub/NP629956.RAGvchlGSNK3J6h03MCzyDdV86iHVeSQxMl2h5YJylbpI#assertion
http://rdf.disgenet.org/resource/nanopub/NP629956.RAGvchlGSNK3J6h03MCzyDdV86iHVeSQxMl2h5YJylbpI
http://www.nanopub.org/nschema#hasProvenance
http://rdf.disgenet.org/resource/nanopub/NP629956.RAGvchlGSNK3J6h03MCzyDdV86iHVeSQxMl2h5YJylbpI#provenance
http://rdf.disgenet.org/resource/nanopub/NP629956.RAGvchlGSNK3J6h03MCzyDdV86iHVeSQxMl2h5YJylbpI
http://www.nanopub.org/nschema#hasPublicationInfo
http://rdf.disgenet.org/resource/nanopub/NP629956.RAGvchlGSNK3J6h03MCzyDdV86iHVeSQxMl2h5YJylbpI#publicationInfo
http://rdf.disgenet.org/resource/nanopub/NP629956.RAGvchlGSNK3J6h03MCzyDdV86iHVeSQxMl2h5YJylbpI
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.nanopub.org/nschema#Nanopublication
http://rdf.disgenet.org/resource/nanopub/NP629956.RAGvchlGSNK3J6h03MCzyDdV86iHVeSQxMl2h5YJylbpI#assertion
http://rdf.disgenet.org/resource/gda/DGN2f7d1b9f07e076e15661c7a8a57c88d7
http://semanticscience.org/resource/SIO_000628
http://identifiers.org/ncbigene/3845
http://rdf.disgenet.org/resource/gda/DGN2f7d1b9f07e076e15661c7a8a57c88d7
http://semanticscience.org/resource/SIO_000628
http://linkedlifedata.com/resource/umls/id/C0948380
http://rdf.disgenet.org/resource/gda/DGN2f7d1b9f07e076e15661c7a8a57c88d7
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://semanticscience.org/resource/SIO_001122
http://rdf.disgenet.org/resource/nanopub/NP629956.RAGvchlGSNK3J6h03MCzyDdV86iHVeSQxMl2h5YJylbpI#provenance
http://rdf.disgenet.org/resource/nanopub/NP629956.RAGvchlGSNK3J6h03MCzyDdV86iHVeSQxMl2h5YJylbpI#assertion
http://purl.org/dc/terms/description
[Patients with metastatic colorectal cancer who had progressed on therapy with 5-FU, oxaliplatin and irinotecan in the first and second line setting and on the combination of irinotecan and cetuximab in third line setting independent of their KRAS mutation status, were treated with irinotecan and cetuximab combined with bevacizumab in a dosage of 5 mg/kg.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
http://rdf.disgenet.org/resource/nanopub/NP629956.RAGvchlGSNK3J6h03MCzyDdV86iHVeSQxMl2h5YJylbpI#assertion
http://purl.org/ontology/wi/core#evidence
http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature
http://rdf.disgenet.org/resource/nanopub/NP629956.RAGvchlGSNK3J6h03MCzyDdV86iHVeSQxMl2h5YJylbpI#assertion
http://semanticscience.org/resource/SIO_000772
http://identifiers.org/pubmed/21529301
http://rdf.disgenet.org/resource/nanopub/NP629956.RAGvchlGSNK3J6h03MCzyDdV86iHVeSQxMl2h5YJylbpI#assertion
http://www.w3.org/ns/prov#wasDerivedFrom
http://rdf.disgenet.org/v5.0.0/void/BEFREE
http://rdf.disgenet.org/resource/nanopub/NP629956.RAGvchlGSNK3J6h03MCzyDdV86iHVeSQxMl2h5YJylbpI#assertion
http://www.w3.org/ns/prov#wasGeneratedBy
http://purl.obolibrary.org/obo/ECO_0000203
http://rdf.disgenet.org/v5.0.0/void/BEFREE
http://purl.org/pav/importedOn
2017-02-19
http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.obolibrary.org/obo/ECO_0000212
http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature
http://www.w3.org/2000/01/rdf-schema#comment
Gene-disease associations inferred from text-mining the literature.
http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature
http://www.w3.org/2000/01/rdf-schema#label
DisGeNET evidence - LITERATURE
http://rdf.disgenet.org/resource/nanopub/NP629956.RAGvchlGSNK3J6h03MCzyDdV86iHVeSQxMl2h5YJylbpI#publicationInfo
http://rdf.disgenet.org/resource/nanopub/NP629956.RAGvchlGSNK3J6h03MCzyDdV86iHVeSQxMl2h5YJylbpI
http://purl.org/dc/terms/created
2017-10-17T13:14:12+02:00
http://rdf.disgenet.org/resource/nanopub/NP629956.RAGvchlGSNK3J6h03MCzyDdV86iHVeSQxMl2h5YJylbpI
http://purl.org/dc/terms/rights
http://opendatacommons.org/licenses/odbl/1.0/
http://rdf.disgenet.org/resource/nanopub/NP629956.RAGvchlGSNK3J6h03MCzyDdV86iHVeSQxMl2h5YJylbpI
http://purl.org/dc/terms/rightsHolder
http://rdf.disgenet.org/v5.0.0/void/IBIGroup
http://rdf.disgenet.org/resource/nanopub/NP629956.RAGvchlGSNK3J6h03MCzyDdV86iHVeSQxMl2h5YJylbpI
http://purl.org/dc/terms/subject
http://semanticscience.org/resource/SIO_000983
http://rdf.disgenet.org/resource/nanopub/NP629956.RAGvchlGSNK3J6h03MCzyDdV86iHVeSQxMl2h5YJylbpI
http://purl.org/net/provenance/ns#usedData
http://rdf.disgenet.org/v5.0.0/void/disgenetv3.0rdf
http://rdf.disgenet.org/resource/nanopub/NP629956.RAGvchlGSNK3J6h03MCzyDdV86iHVeSQxMl2h5YJylbpI
http://purl.org/pav/authoredBy
http://orcid.org/0000-0001-5999-6269
http://rdf.disgenet.org/resource/nanopub/NP629956.RAGvchlGSNK3J6h03MCzyDdV86iHVeSQxMl2h5YJylbpI
http://purl.org/pav/authoredBy
http://orcid.org/0000-0002-7534-7661
http://rdf.disgenet.org/resource/nanopub/NP629956.RAGvchlGSNK3J6h03MCzyDdV86iHVeSQxMl2h5YJylbpI
http://purl.org/pav/authoredBy
http://orcid.org/0000-0002-9383-528X
http://rdf.disgenet.org/resource/nanopub/NP629956.RAGvchlGSNK3J6h03MCzyDdV86iHVeSQxMl2h5YJylbpI
http://purl.org/pav/authoredBy
http://orcid.org/0000-0003-0169-8159
http://rdf.disgenet.org/resource/nanopub/NP629956.RAGvchlGSNK3J6h03MCzyDdV86iHVeSQxMl2h5YJylbpI
http://purl.org/pav/authoredBy
http://orcid.org/0000-0003-1244-7654
http://rdf.disgenet.org/resource/nanopub/NP629956.RAGvchlGSNK3J6h03MCzyDdV86iHVeSQxMl2h5YJylbpI
http://purl.org/pav/createdBy
http://orcid.org/0000-0003-0169-8159
http://rdf.disgenet.org/resource/nanopub/NP629956.RAGvchlGSNK3J6h03MCzyDdV86iHVeSQxMl2h5YJylbpI
http://purl.org/pav/version
v5.0.0.0
http://rdf.disgenet.org/v5.0.0/void/disgenetv3.0rdf
http://purl.org/pav/version
v5.0.0